Latest 6 stories · newest Oct 29, 2026
West reported Q3 2026 net sales and adjusted EPS exceeding expectations. The company increased full-year 2026 net sales and adjusted-diluted EPS guidance, along with announcing a fourth-quarter dividend increase.
West Pharmaceutical Services, Inc. entered into a new $2.8 billion credit agreement dated October 26, 2026, with banks, including Bank of America, JPMorgan Chase, U.S. Bank, and Wells Fargo, to support its global operations. This Instrument is a critical development for the company's 2026-2027 capit…
West Pharmaceutical Services reported strong financial results for the second quarter of 2026, exceeding expectations due to robust sales growth in proprietary products. The company raised its full-year revenue and adjusted EPS guidance.
West Pharmaceutical Services has entered into an executive employment agreement with Michel Lagarde to serve as President and CEO starting August 31, 2026, with Board appointment. The move signals leadership succession planning for the medical device packaging company.
The same WST feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/WST/newsSTART FREE